Dec-21 – CRI Report

Electric Vehicle Virtual Prototyping Market – A Global and Regional Analysis: Focus on Product Type, Application Type, Deployment Type, and Region – Analysis and Forecast, 2019-2030

admin — Thu, 13 Jan 2022 01:14:11 +0000

Market Report Coverage – Electric Vehicle Virtual Prototyping Market

Market Segmentation

• Application Type: ECU, Electronic Systems, Sensor, Battery Systems, Charging Systems, ADAS and Autonomous System, Motor and Motor Controller, Others
• Product Type: Designing, Simulation, Validation
• Deployment Type: On-Premises, Cloud

Regional Segmentation

• North America: U.S., Canada, and Mexico
• Europe: Germany, France, and Rest-of-Europe
• U.K.
• China
• Asia-Pacific and Japan: Japan, South Korea, India, and Rest-of-Asia-Pacific
• Rest-of-the-World

Market Growth Drivers

• Need for Rapid Product Testing and Enhancing Ergonomics and Usability
• Increasing Accuracy in Virtual Prototyping
• Need for Discovery of Design and Software Problems

Market Challenges

• High Cost of Virtual Prototyping

Market Opportunities

• Scope of Innovative Prototyping Technologies
• Growing Market for Electric Vehicle

Key Companies Profiled

Synopsys, Altair Engineering, Inc., Claytex Services Ltd, dSPACE GmbH, Elektrobit Automotive GmbH, EOMYS Engineering, ESI Group, Siemens, Waterloo Maple Inc., Autodesk Inc., Cadence Design Systems, Inc., ANSYS Inc., PTC Inc, Arm Ltd, Dassault Systèmes SE

How This Report Can Add Value

This extensive report can help with:

• A dedicated section focusing on the futuristic trends adopted by the key players operating in the global electric vehicle virtual prototyping market
• Extensive competitive benchmarking of top 15 players offering a holistic view of the global electric vehicle virtual prototyping market landscape
• Qualitative and quantitative analysis of electric vehicle virtual prototyping market at the region and country-level and granularity by application and product segments

Product/Innovation Strategy: The product segment helps the readers in understanding the different types of electric vehicle virtual prototyping used in vehicles. Also, the study provides the readers with a detailed understanding of the electric vehicle virtual prototyping market by application and product.

Key Questions Answered in the Report:

• What are the key drivers and challenges in the global electric vehicle virtual prototyping?
• How does the supply chain function in the global electric vehicle virtual prototyping?
• Which vehicle type segment is expected to witness the maximum demand growth in the global electric vehicle virtual prototyping during 2021-2030?
• What are the key application areas for different product types that may experience high demand during the forecast period, 2021-2030?
• Who are the key suppliers of different electric vehicle virtual prototyping?
• What are the key offerings of the prominent service providers in the global market for electric vehicle virtual prototyping?
• Which regions and countries are leading in terms of consumption of global electric vehicle virtual prototyping, and which of them are expected to witness high demand growth from 2021 to 2030?
• What are the key consumer attributes in various regions for electric vehicle virtual prototyping?

Electric Vehicle Virtual Prototyping

A virtual prototype, also known as a digital mock-up, is a computer simulation of a physical product that can be presented, analyzed, and tested as if it were a real physical model from product life-cycle aspects such as design/engineering, manufacturing, service, and recycling. Virtual prototyping is the process of creating and testing a virtual prototype (VP).

Electric Vehicle Virtual Prototyping Market Overview

The global electric vehicle virtual prototyping market is expected to reach $5,613.2 million by 2030, with a CAGR of 33.83% during the forecast period 2021-2030.

Dominating Segments:

North America

North America is currently the most advanced and competitive automotive market in terms of electric vehicle production and distribution. The presence of automotive giants such as Ford, Tesla, GM, and Fiat Chrysler are responsible for the cruising production of electric vehicles in the region. Companies created a forum where they could discuss, learn, and share with experts from all over the region as manufacturers increasingly focus on the exponential power of information and communication technologies (ICT) with its associated high-performance computing (HPC), machine learning, and Internet of Things (IoT).

Key Market Players and Competition Synopsis

The companies profiled in the report have been selected post undergoing in-depth interviews with experts and understanding details around companies such as product portfolios, annual revenues, market penetration, research and development initiatives, and domestic and international presence in the electric vehicle virtual prototyping market.

The post Electric Vehicle Virtual Prototyping Market – A Global and Regional Analysis: Focus on Product Type, Application Type, Deployment Type, and Region – Analysis and Forecast, 2019-2030 first appeared on CRI Report.

Global Non-Invasive Prenatal Testing Market: Focus on Method, Test, Platform, End User, Application and Country Analysis – Analysis and Forecast, 2020-2031

admin — Thu, 13 Jan 2022 01:14:11 +0000

Market Report Coverage – Non-Invasive Prenatal Testing Market

Market Segmentation

• By Test – Panorama and Vistara; MaterniT GENOME, MaterniT 21 PLUS, informaSeq, Verifi and Verifi Plus Prenatal Tests; Harmony Test; NIFTY Test and NIFTY Test Pro; QNatal Advanced; PrenaTest, GeneSafe, and PrenatalSAFE; Bambni Test; IONA and Sage; and Others
• By Platform – PCR, Next-Generation Sequencing, and Others
• By Method – cfDNA and FCMB
• By End User – Hospitals, Clinics, Diagnostic Labs, and Others
• By Application – Trisomy Detection, Microdeletion Detection, Sex Chromosome Aneuploidy Detection, Others

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, U.K., France, Italy, Switzerland, Spain, Netherlands, Belgium, Russia, Poland, Denmark, Sweden, and Rest-of-Europe
• Asia-Pacific – China, Australia, Japan, India, South Korea, Hong Kong, Malaysia, Indonesia, Vietnam, Thailand, Philippines, and Rest-of-Asia-Pacific
• Latin America
• Rest-of-the-World

Market Growth Drivers

• Increased Emphasis on Early Detection and Prevention
• Availability of Advanced Screening Technologies
• Increasing Consumer Demand
• Shifting of Reimbursement Policies Toward More Genetics Coverage
• High Incidence Rate of Down’s Syndrome
• Rising Average Maternal Age
• Increasing Prevalence of Genetic and Congenital Disorders

Market Challenges

• Stringent Regulatory Guidelines and Ethical Hurdles
• Limitations of NIPT
• Lack of Awareness Among Consumers
• Alternative Screening and Testing Methods

Market Opportunities

• Capitalizing on the Potential Presented by the Emerging Markets in Asia
• Availability of Direct-to-Consumer Tests
• Focus on Pre-Implantation Genetic Diagnosis

Key Companies Profiled

Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, PerkinElmer, Inc., Quest Diagnostics Incorporated, Illumina, Inc., Myriad Genetics, Inc., BGI, CENTOGENE N.V., Laboratory Corporation of America Holdings, MedGenome Inc., Annoroad Gene Technology, Natera, Inc., Yourgene Health PLC, Next Biosciences, Eurofins Scientific

Key Questions Answered in this Report:

• What is the importance of NIPT, and what are the different NIPT products/services available in the market? What are the different methods of NIPT, and what are the benefits and risks associated with it?
• What are the major technological advancements witnessed by the global NIPT market in the past four years, and what is the future scope of the market? What are the key trends of the global NIPT market as per the year 2020, and how is the market evolving currently?
• What was the market size of the global NIPT market in 2020, and what is the market size anticipated to be in 2031? What is the expected growth rate of the global NIPT market during the period 2021-2031?
• What is the market scenario and growth potential of different regions of the world, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
• What are the major drivers, challenges, and opportunities of the global NIPT market?
• Who are the major key players of the global NIPT market? How much market share does each of these players occupy in the market in 2019? Which companies are anticipated to be highly disruptive in the future, and why?
• What is the regulatory scenario of the global NIPT market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of NIPT products?
• What is the average NIPT cost in different countries? What is the reimbursement scenario of the global NIPT market, and what is the reimbursement rate in different countries of the world, including countries of North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa?
• What is the funding scenario of the market with respect to institutional and academic funding? What is the patent landscape of the market, and which companies stand out for registering the greatest number of patents?
• What are the key developmental strategies implemented by the key players of the global NIPT market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
• What are the different NIPT tests available in the market, and which test type dominates the market in 2020 and 2031 in terms of value and volume?
• What is the global market size (by value and volume) of different types of products of the global NIPT market in 2020? What are the key trends of the market with respect to different kits, assays, and which product is expected to dominate the market in 2031?
• What are the different platforms supported by NIPT products? Which technology type dominated the market in 2020 and is expected to dominate in 2031 (by value and volume)?
• What are the different applications associated with NIPT? What was the contribution of each of the application areas in the global NIPT market for the period between 2021 and 2031 (by value and volume)?
• What is the global NIPT market size (by value and volume) based on different methods? Which method is currently leading the market and why? Which method is expected to lead the market during the forecast period?
• Who are the different end users of the global NIPT market (by value and volume)? Which end-user type is the major contributor of revenue in the market?

Market Overview

Non-invasive prenatal testing (NIPT) is a sophisticated method used for the screening of chromosomal abnormalities developing in the fetus. Currently, NIPT is considered a valuable test for the pregnant women to provide cost-effective and highly efficient early diagnosis of genetic disorders. The growth in the market is attributed to the increasing reimbursement policies and insurance coverage across the globe.

Further, the continued significant investments for genome sequencing by healthcare companies to meet the industry demand and the growing incidence of genetic disorders are the prominent factors propelling the growth of the global NIPT market.

Advancements in genome sequencing technologies reduce turnaround time and the complexity of diagnosis with next generation sequencing (NGS). The NGS technology provides several opportunities to develop the non-invasive diagnostic procedures for an early and accurate detection of various genetic disorders.

The life science industry is witnessing significant growth of NIPT tests developed using the NGS technology. Several biotechnology companies are now indulging in the research and development of such NGS-based NIPT products. Furthermore, the advent of genome sequencing technologies in the life science industry has enabled the companies to detect the genetic diseases at an early stage and provide accurate results to remain competitive in the market.

Our healthcare experts have found global NIPT market as one of the most rapidly evolving markets amongst the other prenatal testing industries. The purpose of this study is to gain a holistic view of the NIPT market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market.

The scope of this report constitutes a detailed study of the tests associated with the global NIPT market across different regions. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

Also, aims at answering various aspects of the global NIPT market with the help of the key factors driving the market, restraints, and challenges that can inhibit the overall market growth and the current growth opportunities that are going to shape the future trajectory of the market expansion

Within the research report, the market has been segmented into ‘platforms,’ ‘tests,’ ‘methods,’ ‘applications,’ ‘end-user’, and ‘regions.’. Each of these segments covers the inclination of the market revenue, underlying patterns, snapshot of the market over the projected years, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The NIPT market is currently at a blooming phase, with the presence of various juggernauts such as Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Illumina, Inc., Agilent Technologies, Inc., BGI, and PerkinElmer Inc., as well as other medium and small-medium enterprises, that are offering wide range of NIPT products and services in the market.

Several companies are attempting to enter the market and sustain themselves in the competition by adopting different strategies varying from partnerships and collaborations to business expansions and product launches.

The post Global Non-Invasive Prenatal Testing Market: Focus on Method, Test, Platform, End User, Application and Country Analysis – Analysis and Forecast, 2020-2031 first appeared on CRI Report.

Robotic-Assisted Imaging Technologies Market – A Global and Regional Analysis: Focus on Imaging Modality, Mobility, Application, End User, and Country-Wise Analysis – Analysis and Forecast, 2021-2030

admin — Thu, 13 Jan 2022 01:14:11 +0000

Market Report Coverage – Robotic-Assisted Imaging Technologies Market

Market Segmentation

• Imaging Modalities – X-Ray, CT, Ultrasound, MRI, and Others
• Application – Diagnosis and Imaging and Treatment
• Mobility – Stationary and Portable
• End User – Hospitals and Ambulatory Surgery Centers and Other Settings
• Region – North America, Europe, Asia-Pacific, and Rest-of-the-World

Regional Segmentation

• North America – U.S. and Canada
• Europe – Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, Benelux Countries, and Rest-of-Europe
• Asia-Pacific – China, Japan, South Korea, India, Australia and New Zealand, and Rest-of-Asia-Pacific
• Rest-of-the-World – Latin America and Middle East and Africa

Market Growth Drivers

• Rise in Minimally Invasive Surgical Procedures Across the Globe
• Evolution in Image Modalities and Features
• Rise in Application of Robotics in Medical Field

Market Challenges

• Robotic Failures Leads to Low Rate of Adoption
• Lack of Acceptance of Robotic Procedures
• Safety and Privacy Concerns Related to Patient’s Data

Market Opportunities

• Increased Prevalence for Misdiagnosis Makes Way for Robotics in Diagnostics and Surgery Domains
• High Growth Opportunity in Emerging Economies

Key Companies Profiled

Brainlab AG, Digisens SAS, Epica International, Inc. (Epica Human Health), General Electric Company, Globus Medical, Inc., Medirob AB, Medtronic plc, Neocis, Inc., Novasignal Corporation, Perfint Healthcare, Renishaw plc, Siemens Healthineers AG, Stereotaxis, Inc., Trivitron Healthcare

How This Report Can Add Value

Who should buy this report?

• Surgical and imaging robotics providers to gain a holistic view of the market potential of various offerings and developing economies for business expansion
• AI-enabled imaging devices, haptics, and cloud service providers
• Established healthcare companies integrating software, machine learning, robotics, haptics, and artificial intelligence (AI) into the radiology field
• Established medical technology companies to gain insights into the market potential, market entry strategies, new technologies in the market, and key competitors

Key questions answered in the report

• What are the key trends that have a strong influence on the global robotic-assisted imaging technologies market? How did the COVID-19 pandemic impact the growth of the robotic-assisted imaging technologies market?
• What are the key development strategies which are implemented by the key players to maintain and capture market share?
• How does the patent landscape of robotic-assisted imaging technologies look like?
• What are the major market drivers, challenges, and opportunities in the global robotic-assisted imaging technologies market?
• Which leading companies are dominating the global robotic-assisted imaging technologies market?
• What are the regulations about the global robotic-assisted imaging technologies market?
• What was the market value of the leading segments and sub-segments of the global robotic-assisted imaging technologies market?
• How is each segment of the global robotic-assisted imaging technologies market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segments by the end of 2030?
• Which region carries the potential for the significant expansion of key companies within the robotic-assisted imaging technologies market?

Global Robotic-Assisted Imaging Technologies Market Overview

The surgical medical specialty has matured to deliver in-depth and precise clinical outcomes for both doctors and patients, as well as to enhance surgical workflow patterns in healthcare systems.

In comparison to prior eras, the healthcare sector is now integrating more advanced technology that is more informed and connected. The use of robotic-assisted imaging technologies makes diagnosis and surgery safer for patients by making it more precise and minimally invasive.

The global robotic-assisted imaging technologies market products include X-ray, CT, ultrasound, MRI, and others under the imaging modalities segment. It can be further segmented based on mobility and application. It is categorized as stationary and portable segments based on mobility, whereas under the application segment, it is categorized as diagnosis and imaging and treatment.

The global robotic-assisted imaging technologies market was valued at $617.7 million in 2020 and is projected to reach $2,207.8 million by the end of 2030, growing at a CAGR of 13.74% during the forecast period 2021-2030.

Market Drivers

Presently, the factors driving the growth of the market include rise in minimally invasive surgical procedures across the globe, evolution in image modalities and features, and rise in applications of robotics in the medical field.

Market Challenges

The challenges that are restricting the growth of the market include robotic failures leading to a low rate of adoption, lack of acceptance of robotic procedures, and safety and privacy concerns related to patient data.

Market Opportunities

Potential opportunities that are likely to boost the growth of the market include increased prevalence for misdiagnosis makes way for robotics in diagnostics and surgery domains high growth opportunities in emerging economies.

Impact of COVID-19

The COVID-19 pandemic had an ambiguous impact on the robotic-assisted imaging technologies market. Few of the imaging modalities, such as X-ray and CT, were used for screening during the COVID-19 pandemic, whereas the majority of the imaging modalities were not used due to postponement of elective surgeries and procedures during the pandemic.

In the first half of 2020, the COVID-19 pandemic had a significant influence on elective surgical procedures. On a global scale, the COVID-19 pandemic also significantly impacted regular hospital routine services. During the early stages of the pandemic, hospitals drastically restricted or stopped performing elective surgical procedures to ensure patient safety and to focus on COVID-19 patients.

Market Segmentation

by Imaging Modalities

Under this segmentation, the market is categorized into X-ray, CT, ultrasound, MRI, and others.

The X-ray segment is expected to grow at the highest CAGR of 12.87% during the forecast period 2021-2030.

by Mobility

Under this segmentation, the market is categorized into stationary and portable.

The stationary segment is expected to grow at the highest CAGR of 13.43% during the forecast period 2021-2030.

by Application

Under this segmentation, the market is categorized into diagnosis and imaging and treatment. The diagnosis and imaging segment is expected to grow at the highest CAGR of 13.48% during the forecast period 2021-2030.

by Region

The different regions covered under the market report include North America, Europe, Asia-Pacific, and Rest-of-the-World.

North America dominated the market in 2020 and is anticipated to uphold its dominance throughout the forecast period 2021-2030. The growth in the market is majorly driven by the increasing research and development activities and many companies being located in the U.S.

Key Market Players and Competition Synopsis

Some key players operating in the market include Brainlab AG, Digisens SAS, Epica International, Inc. (Epica Human Health), General Electric Company, Globus Medical, Inc., Medirob AB, Medtronic plc, Neocis, Inc., Novasignal Corporation, Perfint Healthcare, Renishaw plc, Siemens Healthineers AG, Stereotaxis, Inc., and Trivitron Healthcare

The robotic-assisted imaging technologies market has witnessed several strategic and technological developments from January 2017- November 2021, undertaken by different market players to attain their respective market shares in this emerging domain. Some strategies covered in this segment are product development and upgradation, partnerships, collaborations, business expansion, funding activities, regulatory approvals, mergers, and acquisitions. The preferred strategy for companies has been regulatory activities.

The post Robotic-Assisted Imaging Technologies Market – A Global and Regional Analysis: Focus on Imaging Modality, Mobility, Application, End User, and Country-Wise Analysis – Analysis and Forecast, 2021-2030 first appeared on CRI Report.

Global Viral and Non-Viral Vector Manufacturing Market: Focus on Vector Type, Application, Disease and Region – Analysis and Forecast, 2021-2031

admin — Thu, 13 Jan 2022 01:14:11 +0000

Market Report Coverage – Viral and Non-Viral Vector Manufacturing Market

Market Segmentation

• Vector Type – Viral Vector and Non-Viral Vector
• Disease – Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases
• Application – Gene Therapy, Vaccinology, Cell Therapy, and Other Applications

Regional Segmentation

• North America: U.S., Canada
• Europe: Germany, U.K., France, Italy, Switzerland, Belgium, Spain, and Rest-of-Europe
• Asia-Pacific: China, India, Japan, Australia, South Korea, Singapore, and Rest-of-Asia-Pacific
• Rest-of-the-World

Market Growth Drivers

• Rapid Uptake of Viral Vector to Develop Innovative Therapies
• Increasing Number of Clinical Studies for the Development of Gene Therapy
• Favorable Funding Scenario for Vector-Based Therapies
• Increasing Adoption of Nucleic Acid Therapeutics
• Rise in Synergistic Activities in the Market

Market Challenges

• Unaffordable Cost of Gene Therapy
• High Manufacturing Cost of Viral Vectors
• Complications Associated with Large-Scale Production of Viral Vectors
• Low Transfection Efficiency

Market Opportunities

• Rise in Demand for Synthetic Genes
• Emergence of Next-Generation Vectors
• Limitation of Viral Vectors

Key Companies Profiled

Boehringer Ingelheim, Catalent, Inc., FUJIFILM Holdings Corporation, Danaher Corporation, Genscript Biotech Corporation, Lonza Group AG, Merck KGaA Inc., Oxford Biomedica plc, Sartorius AG, Takara Bio Inc., Thermo Fisher Scientific Inc., Wuxi AppTec, Acuitas Therapeutics, Evonik Industries AG, Exelead, Inc., Entos Pharmaceuticals, Genevant Sciences GmbH, T&T Scientific Corporation, Moderna, Inc., CureVac N.V.

Key Questions Answered in this Report:

• What is a vector, and what is its importance in the medical industry? What are the major characteristics and types of vectors? What are the areas of application of vectors?
• What are the major advancements in viral and non-viral vector manufacturing? What are the key trends of the global viral and non-viral vector manufacturing market? How is the market evolving, and what is its future scope?
• What are the major drivers, challenges, and opportunities of the global viral and non-viral vector manufacturing market?
• What are the key developmental strategies implemented by the key players of the global viral and non-viral vector manufacturing market to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies?
• What is the regulatory scenario of the global viral and non-viral vector manufacturing market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of viral and non-viral vector manufacturing products?
• What are major milestones in patenting activity in the global viral and non-viral vector manufacturing market?
• What was the market size of the global viral and non-viral vector manufacturing market in 2020, and what is the market size anticipated to be by 2031? What is the expected growth rate of the global viral and non-viral vector manufacturing market during the forecast period 2021-2031?
• What is the global market size for manufacturing different types of viral and non-viral vectors available in the global viral and non-viral vector manufacturing market? What are the key trends of the market with respect to different vectors, and which vector type is expected to dominate the market in 2031?
• What are the different disease areas where non-viral vectors and viral vectors are employed in the global viral and non-viral vector manufacturing market? Which disease type dominated the market in 2020 and is expected to dominate in 2031?
• What are the different applications associated with the viral vector and non-viral vector manufacturing? What was the contribution of each of the application areas in the global viral and non-viral vector manufacturing market in 2020, and what is it expected in 2031?
• Which region is expected to contribute the highest sales in the global viral and non-viral vector manufacturing market during the period 2021-2031? Which region and country carries the potential for the significant expansion of key companies for different viral and non-viral vector manufacturing? What are the leading countries of different regions that contribute significantly toward the growth of the viral and non-viral manufacturing market?
• What are the key players of the global viral and non-viral vector manufacturing market, and what are their roles in the market? What were the market shares of the key players in 2020?

Market Overview

The advent of advanced therapies, including gene therapy and cell therapy, which employ the use of vectors, has created a huge impact in the field of medicine in the past few decades.

Therapies that require genetic modification, including the introduction of therapeutic deoxyribonucleic acid (DNA)/gene into a patient’s body or cell, demonstrated tremendous potential for treating several fatal diseases, including cancer, Alzheimer’s disease, Parkinson’s disease, and rheumatoid arthritis, among others.

Promising results displayed by these vector-based therapies in several preclinical and clinical studies have further emphasized the development and standardization of various viral and non-viral vectors to address unmet medical needs.

The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.

Known to reduce the cost of treatment and help decrease repeated administration of medications, viral vectors, and non-viral vectors have gained significant attention globally as a novel therapeutic approach for treating various critical diseases, thereby promoting a surge of investments in drug development and commercialization.

Growing prominence of gene and cell therapy products (that utilize vectors) and increasing funding activities driving research related to vector-based therapies are the key driving factors fuelling the growth of the global viral and non-viral vector manufacturing market.

Moreover, rising incidences of genetic disorders, cancers, and infectious diseases, coupled with the increasing number of clinical studies and robust pipeline of gene and cell therapy products as well as vector-based vaccines, are the additional driving factors encouraging market growth.

Competitive Landscape

The global viral and non-viral vector manufacturing market comprises well-established and newly emerging companies. Several companies are attempting to enter the market and sustain the competition by adopting synergistic activities and expanding their business by launching manufacturing capacities or developing proprietary viral and non-viral vector platforms.

In the past three years (2018-2020), the key market players of the global viral and non-viral vector manufacturing market witnessed majorly synergistic activities, business expansion, and funding activities. The inclination of companies toward synergies suggests that the companies are collaborating with viral and non-viral vector manufacturers to develop novel cell therapies, gene therapies, and vaccines for various diseases. The expansion of manufacturing capacities suggests that the companies are trying to fulfill the increased demand for vectors for cell and gene therapies.

The post Global Viral and Non-Viral Vector Manufacturing Market: Focus on Vector Type, Application, Disease and Region – Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Carrier Screening Market – A Global and Regional Analysis: Focus on Type, Product, Carrier Screening Type, Technology, Indication, and Region – Analysis and Forecast, 2021-2031

admin — Thu, 13 Jan 2022 01:14:11 +0000

Market Report Coverage – Carrier Screening Market

Market Segmentation

• Type (Expanded Carrier Screening and Targeted Carrier Screening)
• Product (In Vitro Diagnostics And Laboratory Developed Tests)
• Carrier Screening Type (Prenatal Carrier Screening And Preconception Carrier Screening)
• Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, And Other Technologies)
• Indication (Fragile X Syndrome, Cystic Fibrosis, Spinal Muscular Atrophy, Down’s Syndrome, Thalassemia, Tay-Sachs Disease, Huntington’s Disease, Sickle Cell Anemia, Hemophilia, and Other Indications)

Regional Segmentation

• North America: U.S., Canada
• Europe: Germany, France, U.K, Italy, Spain, Netherlands, Denmark, Belgium, Switzerland and Rest-of-Europe
• Asia-Pacific: China, Japan, India, South Korea, Australia, Singapore, Rest-of-Asia-Pacific
• Latin America: Brazil, Mexico, Rest-of-Latin America
• Rest-of-the-World

Market Growth Drivers

• Decreasing Cost of Sequencing
• Rising Emphasis on Early Detection and Prevention of Complex Genetic Disorders
• Increasing Maternal Age Leading to Pregnancy Complications
• Rising Funding and Innovation in the carrier Screening Ecosystem

Market Challenges

• Regulatory Challenges in the Field of Carrier Screening
• Lack of High Complexity Testing Centers
• Existing Diagnostic Confidence on Conventional Screening Methods

Market Opportunities

• Massive Scope for Adoption of Carrier Screening in Developing Nations

Key Companies Profiled

BGI Group, CENTOGENE N.V., Eurofins Scientific, Fulgent Genetics, Inc., Gene by Gene, Ltd., Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Natera, Inc., OPKO Health, Quest Diagnostics Incorporated, Sema4, Thermo Fisher Scientific Inc., Yourgene Health Plc

Key Questions Answered in this Report:

• How is carrier screening revolutionizing the field of reproductive health?
• What are the major market drivers, challenges, and opportunities in the global carrier screening market?
• What are the underlying structures resulting in the emerging trends within the global carrier screening market?
• How is the COVID-19 pandemic impacting the global carrier screening ecosystem??
• What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to the use of carrier screening?
• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
• How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
o Type (expanded carrier screening and targeted carrier screening)
o Product (in vitro diagnostics and laboratory developed tests)
o Carrier Screening Type (prenatal carrier screening and preconception carrier screening)
o Technology (next-generation sequencing, polymerase chain reaction, microarray, and other technologies)
o Indication (fragile X syndrome, cystic fibrosis, spinal muscular atrophy, Down’s Syndrome, thalassemia, Tay-Sachs Disease, Huntington’s Disease, sickle cell anemia, hemophilia, and other indications)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the growth opportunities for the carrier screening companies in the region of their operation?
• Who are the leading players with significant offerings in the global carrier screening market?
• Which companies are anticipated to be highly disruptive in the future, and why?

Market Overview

The growth of the carrier screening market is expected to be driven by the decrease in the cost of sequencing, rising emphasis on early detection and prevention of complex genetic disorders, and increasing maternal age leading to pregnancy complications.

However, there are significant challenges restraining the market growth, such as the regulatory challenges in the field of carrier screening, and the lack of high complexity testing centers. Carrier screening is a hereditary test that gives information about whether a person carries a gene for certain genetic disorders.

It is performed before or during pregnancy times. Carrier screening allows a person to find out the chances of having a child with a genetic disorder.

Carrier screening involves testing blood, saliva, or tissue extracted from inside the cheeks. In cases of genetic disorders, a person should have two affected genes to have the disorder. A person who is a carrier has only one gene for a disorder and usually does not have symptoms or have only mild symptoms.

The current market for carrier screening is majorly dominated by manufacturers and service providers such as BGI Group, CENTOGENE N.V., Eurofins Scientific, Fulgent Genetics, Inc., Gene by Gene, Ltd., Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Natera, Inc., OPKO Health, Quest Diagnostics Incorporated, Sema4, Thermo Fisher Scientific Inc., and Yourgene Health Plc.

The global carrier screening market is projected to reach $4,479.0 million by 2031, growing from $1,187.4 million in 2020, at a CAGR of 12.67% during the forecast period 2021-2031.

The carrier screening market is an emerging market with huge growth potential. Recent technological advancements are facilitating the adoption of the technology at a rapid pace. Carrier screening are genetic tests that are used for determining if a person is a potential carrier of genetic disorders such as cystic fibrosis (CF), Down’s syndrome, Fragile X syndrome, sickle cell anemia, and spinal muscular atrophy (SMA).

Carrier screening tests are extensively used by couples considering becoming pregnant to determine the risks of passing genetic anomalies to the child. This study aims at deciphering the potential of carrier screening and its larger role in bolstering the current era of precision medicine in the field of reproductive health.

Competitive Landscape

The growth of this market can be majorly attributed to the presence of well-established guidelines regarding carrier screening, presence of established companies undertaking key business strategies, decrease in the cost of sequencing, rising emphasis on early detection and prevention of complex genetic disorders, and increasing maternal age leading to pregnancy complications, among others.

Further, increasing focus on research pertaining to carrier screening such as targeted carrier screening in spinal muscle atrophy and emerging application of preconcecption carrier screening is also expected to support the growth of the carrier screening market during the forecast period, 2021-2031.

The growth of other technologies, such as next-generation sequencing and PCR can be attributed to the increased clinical research to understand the involvement of molecular pathology in the diagnosis and prognosis of genetic disorders.

Based on region, North America holds the largest share in the market, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.

The post Carrier Screening Market – A Global and Regional Analysis: Focus on Type, Product, Carrier Screening Type, Technology, Indication, and Region – Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Aseptic Pharma Processing Market – Global and Regional Analysis: Focus on Product, Technology, Regional and Country Analysis – Analysis and Forecast, 2021-2031

admin — Thu, 13 Jan 2022 01:14:10 +0000

Market Report Coverage – Aseptic Pharma Processing Market

Market Segmentation

• Product – Corticosteroids, Long-Acting Beta Agonists/Long-Acting Muscarinic Antagonists, Antibiotics, and Others
• Technology – Drying, Lyophilization, Closed Vial Technology, Blow-Fill-Seal Technology, and Others

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain, and Rest-of-Europe
• Asia-Pacific – China, Japan, Australia, India, South Korea, and Rest-of-Asia-Pacific (RoAPAC)
• Rest-of-the-World

Market Growth Drivers

• Reduced Risk of High-Cost Product Loss
• High Growth in the Generics and Biopharmaceuticals Markets
• Growing Demand for Contract Manufacturing Organizations (CMOs) for Aseptic Manufacturing of Pharmaceutical Products

Market Challenges

• High Capital Investment
• Lack of Skilled Personnel

Market Opportunities

• Emergence of Data within the Aseptic Processing Industry
• Growing Demand for Automated Products in Aseptic Pharma Processing at the Pharmaceutical Companies
• Increasing Investment in R&D

Key Companies Profiled

Abbvie Inc., Lonza Group, Baxter International Inc., August Bioservices, Vetter Pharma, Recipharm AB, Berkshire Sterile Manufacturing, Recro Pharma, Curia, Samsung Biologics, Symbiosis Pharmaceutical Services, Catalent Pharma Solutions Inc., Alcami Corporation, Wuxi AppTec

Key Questions Answered in this Report:

• What are the major drivers, challenges, and opportunities of the global aseptic pharma processing market?
• What are the key developmental strategies implemented by the key players to stand out in this market?
• Who are the leading companies dominating the global aseptic pharma processing market? What is the share of these companies in the global aseptic pharma processing market?
• What are the regulations pertaining to the global aseptic pharma processing market? What initiatives are implemented by different government bodies regulating the development and commercialization of aseptic pharma processing?
• How is each segment of the global aseptic pharma processing market expected to grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2031?
• How will the industry of aseptic pharma processing evolve during the forecast period 2021-2031?
• What is the market scenario for the aseptic pharma processing market in different regions?
• What are the key trends of different regions in the aseptic pharma processing market? Which country would contribute to the highest sales of the aseptic pharma processing market during the forecast period 2021-2031?
• What has been the impact of COVID-19 on the aseptic pharma processing market?

Market Overview

Aseptic processing has had been in commercial application since the 1950s. The requirement for aseptic manufacturing was raised when there was no suitable sterilization method for heat-sensitive pharmaceutical products that could not be autoclaved in the container. However, the drugs have to be sterile since then, the standards of aseptic manufacturing for the medicinal drugs were specified and standardized.

North America represented one of the most attractive markets amongst all the markets in the world for aseptic pharma processing in 2020. However, Europe is anticipated to gain more market shares than North America in the coming years, which can be attributed to a large number of contract drug manufacturers (CDMOs) present in the region.

Also, the demand for aseptic processing is higher in European countries. However, China is expected to be the fastest-growing nation globally, with many local manufacturers in the region.

The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.

The growth is attributed to the reduced risk of high-cost product loss, high growth in the generics and biopharmaceuticals markets, and growing demand for contract manufacturing organizations (CMOs) for aseptic manufacturing of pharmaceutical products.

Further, continued significant investments by biotechnology firms to improve the aseptic processing technology by incorporating automated instruments has also promoted the prominence of the aseptic pharma processing market.

Within the research report, the market is segmented based on product, technology, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the demand for biopharmaceuticals such as vaccines and other drugs have lead to an increase in the aseptic processing facilities to manufacture pharmaceuticals in a standardised mode. Further, the expansion in the number of CDMOs have also allowed the adoption of specific aseptic processing technologies.

Companies such as Baxter International have been incorporating major strategies to enhance their market presence via key developments. The other major contributors to the market include companies such as Recipharm AB, Recro Pharma, and Lonza Group, among others.

Based on region, North America holds the largest share of the aseptic pharma processing market due to standardized regulatory scenarios and a large number of companies offering aseptic processing.

Further, substantial investments made by biotechnology companies to improve the manufacturing facilities and advancing automation technologies along with the rise in per capita income in the region are also fuelling the growth of the respective market. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.

The post Aseptic Pharma Processing Market – Global and Regional Analysis: Focus on Product, Technology, Regional and Country Analysis – Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Disposable Nitrile Gloves Market Forecast

admin — Thu, 30 Dec 2021 02:27:10 +0000

Disposable Nitrile Gloves Market Forecast

Market Overview
The global disposable nitrile gloves market is expected to record a substantial CAGR OF 14.11 % during the forecast period owing to the largest market value of USD 2,115.48 million in 2020.

Disposable nitrile gloves are made of engineered elastic that takes after latex yet will have better protection from penetrates. Nitrile comes in powdered structure, clean, non-sterile, and presented at various lengths from wrist to lower arm. Disposable nitrile gloves are utilized in working environments across a few enterprises, going from the food handling industry to the aviation and protection businesses.

Over the past few years, the inclination for disposable nitrile gloves has expanded contrasted with latex and vinyl gloves.

The growth of the global disposable nitrile gloves market is anticipated to register a significant market growth to reach the largest market value of USD 5,294.71million by 2027. The global market growth is fuelled by the expanding inclination for the utilization of these gloves in working environments across a few ventures and developing mindfulness on forestalling medical care-related contaminations.

Moreover, the developing number of patients experiencing irresistible sicknesses and the expanding number of medical procedures internationally are supporting the development of the disposable nitrile gloves market. However, the rising expansion of product duplication is set to confine the disposable nitrile gloves market development.

Segment Overview
The global disposable nitrile gloves market has been segmented into type and application.
Global Disposable Nitrile Gloves Market based on type is bifurcated into Powder-free and Powdered.
Based on the Application segment the global market has been divided into Medical and Non-medical.

Regional Analysis
Geographically, the global disposable nitrile gloves market is spread across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas represented a piece of the pie of 42.58% in 2020 and is relied upon to display a CAGR of 12.93% during the gauge time frame. This high extent of the piece of the pie of the Americas can be ascribed to an expansion in imports of disposable nitrile gloves and an expanding number of medical services-related contaminations over the previous decade.

As indicated by the European Centre for Disease Prevention and Control, the normal pervasiveness of HAIs is assessed to be 7.1% in European nations. Among factors bringing about the commonness of such contaminations, insufficient clean conditions and garbage removal are principally dependable.

Asia-Pacific is assessed to be the quickest developing locale for the worldwide disposable nitrile gloves market. This is ascribed to the rising pervasiveness of irresistible sicknesses, like tuberculosis and measles, the developing danger of HAIs &associated hazard mindfulness projects, and medical care improvement help and unfamiliar guide to low-pay nations.

The Middle East and Africa disposable nitrile gloves market is bifurcated into the Middle East and Africa.

Major Players
The prominent players operating in the global disposable nitrile gloves market are Unigloves (UK), Ansell (US), Polyco Healthline (UK), Barber Healthcare (UK), Paul Hartmann (Germany), Robinson Healthcare (UK), Aurelia Gloves (US), Medline Industries (US), 365 Healthcare (UK), and Fannin (Ireland).

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Global Disposable Gloves Market Research Report – Forecast till 2026

Asia-Pacific Cleanroom Disposable Gloves Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

India Disposable Latex Gloves Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

The post Disposable Nitrile Gloves Market Forecast first appeared on CRI Report.

Epilepsy Surgery Market Forecast till 2027

admin — Thu, 30 Dec 2021 02:27:10 +0000

Epilepsy Surgery Market Forecast till 2027

Market Overview
The global epilepsy surgery market is expected to register a notable CAGR of CAGR 5.72% during the review period to surpass USD 1,402.32 million by the end of 2027. The epilepsy surgery is accomplished to minimize the probability of seizures.

Developing business sectors are expected to offer potential development openings for worldwide market players working in the market because of mechanical progressions, the developing old populace inclined to seizure problems, and government drives in endeavor research initiatives on epilepsy medical procedures.

The epilepsy medical procedure market is projected to display critical development over the figure time frame, credited to variables like quick mechanical progressions in the gadgets, better clinical offices, and an expanding patient pool needing careful therapy.

The global epilepsy surgery market is expected to witness a healthy market expansion a significant growth rate owing to the growing incidences of neurological disorders leading to exclusive R&D on epilepsy treatment devices and growing prevalence of brain injuries because of growing road accidents.

Moreover, progresses in a robot-helped medical procedure and an increment in the geriatric populace are probably going to drive market development. Be that as it may, changes related to epilepsy surgeries may restrain the market development.

Market Segmentation
The epilepsy surgery market has been categorized into procedure type and ends user.

By procedure type the global market has been categorized into Resective surgery, Laser Interstitial Thermal Therapy (LITT), and others. In terms of end users, the market has been classified into hospitals & clinics, specialty centers, and others.

Regional Analysis
Geographically, the epilepsy medical procedure market, has been partitioned into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is likely to command the epilepsy medical procedure market owing to different elements, like the accessibility of grounded medical services offices, the high pervasiveness of neurological issues, and the expanding rate of epilepsy.

North America is separated into the US and Canada. It is assessed that approximately 150,000 Americans are determined to have Central Nervous System (CNS) jumble that causes seizures and is the fourth most normal neurological infection.

With expanding interest in research and improvement, the creation of effective epilepsy meds, and a high pervasiveness of epilepsy, Europe has additionally developed as a noticeable market for epilepsy medical procedures.

The Asia-Pacific area offers rewarding freedoms for players in the epilepsy medical procedure market is driven by the presence of an enormous geriatric populace, legislative drives to further develop the medical care area, an increment in research and advancement exercises, and an increment in epilepsy occurrence in the region. The Middle East &Africa epilepsy medical procedure market is fragmented into significant areas, to be specific the Middle East, Africa, and Latin America.

Major Players
The prominent market players operating in the global Epilepsy surgeries market include Stryker (US), Intuitive Surgical (US), Medtronic Plc (Mazor Robotics) (Ireland), Cephalon, Inc. (US), CMR Surgical (UK), Natus Medical Incorporated (US), Zimmer Biomet Holdings Inc. (US), Auris Health, Inc. (Hansen Medical, Inc.) (US), Livanova Plc (UK), and Monteris Medical (US).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Demand for surgical proceduresare expected to boost the growth of the global epilepsy surgery market at a CAGR of 5.72% during the forecast period 2021 to 2027

The post Epilepsy Surgery Market Forecast till 2027 first appeared on CRI Report.

Protein Engineering Market Forecast till 2027

admin — Thu, 30 Dec 2021 02:27:10 +0000

Protein Engineering Market Forecast till 2027

Protein Engineering Market overview
The protein engineering market is anticipated to register a significant CAGR of 7.62% during the review period to surpass USD 3,023.29 million by 2027. Nowadays, the protein engineering market is acquiring fame because of less utilization of non-protein drugs. The consequences of protein drugs are positive in the clinical area.

Because of this, the interest in protein engineering is expanding in numerous areas. Protein engineering has an enormous degree as it can decrease the shortcoming of clinical medications. Likewise, the proficiency and viability of the medication are high.

Generally, the pervasiveness of protein engineering brings about more cardiovascular fixes. The utilization of the protein engineering device is prompting considerably more advantages in the clinical area.

The therapy of disease, immune system, and relocate dismissals are conceivable through protein engineering. Additionally, the all-around designed methods of protein in drugs are giving remarkable outcomes and conveyance. The expanding innovative work interest in the wellbeing area is the vital justification behind the popularity.

Likewise, really advertising and commercialization of the medications is one more justification for more interest. There is a mixture of protein engineering techniques and applications in the impending years.

Particularly the biotechnical drug organization holds the most extreme protein piece of the pie. The ascent of the reception of silicon model protein in this area is promoting a positive effect on the protein engineering market. It will prompt further improvement of the general market.

Segment overview
The global protein engineering market has been classified based on product, protein type, technology, and end-user.

In terms of product segment, the global market has been divided into Instruments, Consumables, and Services, and software. Based on Protein type the market has been classified into Coagulation factors, Monoclonal antibodies, Growth hormones, Vaccines, Vaccines, and Interferon.

Based on Technology type the market has been categorized into Irrational protein design and Rational protein design.
The End-user segment segregates the global protein engineering market into Academic research institutes, biopharmaceutical companies, and Contract research organizations.

Regional analysis
The region-specific analysis of the global protein engineering market is studied across Asia Pacific, North America, and Europe.

North America is set to overwhelm the market with the biggest offer. Further, the developing venture is the main consideration for a market extension. The market advancement rate will be higher for the North American region. The rising technique of extent protein engineering is driving more interest.

The Asia Pacific market is rapidly occupying in the projected timeframe. The high advancement is a direct result of more care about protein engineering. The progression in genomics is the earnest driver for the market.

Further, the advancement of proteomics is higher around here. The regulatory drives for the medicine-based market are higher. The allotments support protein engineering turning out to be more. Additionally, Europe is standing up to direct revenue for the market around here. Europe will see greater improvement during the review period.

Prominent Players
The key player of the protein engineering market is ProteoGenix, Bio-Rad Laboratories, PhyNexus, Inc, Thermo Fisher Scientific, Broker Corporation, Zymeworks, Inc, Waters Corporation, Aspira Chemical, Danaher Corporation, InvivoGen, New England Biolabs, Enantis S.R.O, New England Biolabs, Promega Corporation, and New England Biolabs.

Protein supplements market : Global Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030

The post Protein Engineering Market Forecast till 2027 first appeared on CRI Report.

Calcined Bauxite Market Forecast till 2028

admin — Thu, 30 Dec 2021 02:27:10 +0000

Calcined Bauxite Market Forecast till 2028

Market Snapshot
The global calcined bauxite market is anticipated to exhibit a notable CAGR of approximately 5.15% during the review period to surpass a predicted market value of USD 2,159million by the end of 2028. The calcination process removes moisture and impurities from bauxite and helps in increasing the alumina content, grain hardness, and refractoriness of the bauxite ore.

This results in calcined bauxite being an ideal material used in the production of various types of refractory materials. This is attributed to its ability to withstand extremely high temperatures and corrosive environments prevailing inside the blast furnaces.

The prime factor driving the growth of the global calcined bauxite market is its extensive use for brown fused alumina, further used to produce refractory materials. Calcined bauxite, anthracite, iron filings, and additives are mixed in specific proportions and heated together at about 2,250℃ temperature to produce brown fused alumina.

The growing use of high alumina refractories in the steel production process is likely to fuel the calcined bauxite market over the forecast period. Moreover, extensive use of brown fused alumina in the production of abrasives is projected to provide an additional boost to the product demand. However, environmental concerns associated with bauxite mining activities may hamper the global market growth.

Market Segmentation
The global calcined bauxite market has been classified into purity, application, and region.
Based on the purity segment, the calcined bauxite market has been bifurcated into high purity (>85%) and low purity (<85%).
In terms of application, the global market has been classified into abrasives, refractory materials, metallurgy, road surfacing, and others.

Regional Analysis
The global calcined Bauxite Market has been studied across Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa. Asia-Pacific emerged as the leading and fastest-growing segment on account of the largest bauxite ore reserves in countries such as India, China, and Australia.

In 2019, Australia remained the largest producer of bauxite at 105 metric tonnes, followed by China and India. In addition to this, lower labor costs coupled with higher manpower in the Asia-Pacific region promote market growth. Widespread use of refractories in end-use industries such as iron and steel, cement & ceramics, non-ferrous metals, and others is a major driver of the regional market growth.

Growing infrastructure in emerging countries such as India, Thailand, and South Korea coupled with the rising demand for refractories from the iron & steel industry is the prime factor driving the market in upcoming years.

North America is expected to have a significant share in the global market owing to the high demand for metal abrasives and alumina products. Growing automotive, metal fabrication, machinery, electronics, electrical, medical, and construction industries in the US contribute to the growth of the abrasives market.

Key Players
The key market players of the global calcined market are Great Lakes Minerals, LLC(US), LKAB (Sweden), Boud Minerals Limited (UK), Saurashtra Calcine Bauxite & Allied Industries Ltd (India), EK-COMPANY AG (Germany), Bosai Group (China), First Bauxite LLC (US), and Sinocean Industrial Limited (China).

The post Calcined Bauxite Market Forecast till 2028 first appeared on CRI Report.